Affiliation: Atrium Medical Centre
Country: The Netherlands
- Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromesTimo Lenderink
Department of Cardiology, Atrium Medical Centre, Heerlen, The Netherlands
J Am Coll Cardiol 47:307-11. 2006..This study sought to evaluate the predictive value of baseline placental growth factor (PlGF) for long-term cardiovascular events in acute coronary syndromes (ACS)...
- Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACSTimo Lenderink
Department of Cardiology, Thoraxcentre, Erasmus Medical Centre, Rotterdam, The Netherlands
Am Heart J 147:865-73. 2004..The glycoprotein IIb/IIIa receptor antagonist abciximab reduces the risk of thrombotic complications with percutaneous coronary intervention, but also has been associated with higher bleeding rates...
- Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromesTimo Lenderink
Atrium Medical Centre, Heerlen, The Netherlands
Eur Heart J 27:1799-804. 2006..However, it remains uncertain how soon statins should be started after an acute coronary syndrome (ACS). Recently published trials suggest starting before discharge. We hypothesize that statins should be initiated without delay...
- Prediction of 30-day mortality in older patients with a first acute myocardial infarctionTimo Lenderink
Department of Cardiology, Atrium Medisch Centrum, Heerlen, The Netherlands
Cardiology 115:1-9. 2010..This study sought predictors of mortality in patients aged >or=75 years with a first ST-segment elevation myocardial infarction (STEMI) and evaluated the validity of the GUSTO-I and TIMI risk models...